Genomed Spólka Akcyjna (WSE:GEN)

Genomed Spólka Akcyjna Statistics

Total Valuation

WSE:GEN has a market cap or net worth of PLN 36.73 million. The enterprise value is 31.14 million.

Market Cap	36.73M
Enterprise Value	31.14M

Important Dates

The last earnings date was Thursday, November 13, 2025.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:GEN has 1.32 million shares outstanding.

Current Share Class	648,283
Shares Outstanding	1.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.76%
Owned by Institutions (%)	n/a
Float	41,650

Valuation Ratios

The trailing PE ratio is 11.23.

PE Ratio	11.23
Forward PE	n/a
PS Ratio	1.34
PB Ratio	2.95
P/TBV Ratio	2.97
P/FCF Ratio	15.67
P/OCF Ratio	10.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.04, with an EV/FCF ratio of 13.29.

EV / Earnings	9.52
EV / Sales	1.13
EV / EBITDA	7.04
EV / EBIT	8.46
EV / FCF	13.29

Financial Position

The company has a current ratio of 8.36

Current Ratio	8.36
Quick Ratio	6.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	6,470.64

Financial Efficiency

Return on equity (ROE) is 29.64% and return on invested capital (ROIC) is 20.85%.

Return on Equity (ROE)	29.64%
Return on Assets (ROA)	18.51%
Return on Invested Capital (ROIC)	20.85%
Return on Capital Employed (ROCE)	28.79%
Revenue Per Employee	518,773
Profits Per Employee	61,718
Employee Count	54
Asset Turnover	2.21
Inventory Turnover	5.17

Taxes

In the past 12 months, WSE:GEN has paid 482,109 in taxes.

Income Tax	482,109
Effective Tax Rate	12.85%

Stock Price Statistics

The stock price has increased by +3.70% in the last 52 weeks. The beta is -0.09, so WSE:GEN's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	+3.70%
50-Day Moving Average	27.61
200-Day Moving Average	26.94
Relative Strength Index (RSI)	48.78
Average Volume (20 Days)	276

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:GEN had revenue of PLN 27.49 million and earned 3.27 million in profits.

Revenue	27.49M
Gross Profit	17.94M
Operating Income	3.68M
Pretax Income	3.75M
Net Income	3.27M
EBITDA	4.42M
EBIT	3.68M
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 5.59 million in cash and n/a in debt, giving a net cash position of 5.59 million or 4.23 per share.

Cash & Cash Equivalents	5.59M
Total Debt	n/a
Net Cash	5.59M
Net Cash Per Share	4.23
Equity (Book Value)	12.45M
Book Value Per Share	n/a
Working Capital	9.09M

Cash Flow

In the last 12 months, operating cash flow was 3.41 million and capital expenditures -1.07 million, giving a free cash flow of 2.34 million.

Operating Cash Flow	3.41M
Capital Expenditures	-1.07M
Free Cash Flow	2.34M
FCF Per Share	1.77

Margins

Gross margin is 65.24%, with operating and profit margins of 13.39% and 11.90%.

Gross Margin	65.24%
Operating Margin	13.39%
Pretax Margin	13.65%
Profit Margin	11.90%
EBITDA Margin	16.08%
EBIT Margin	13.39%
FCF Margin	8.52%

Dividends & Yields

WSE:GEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	8.91%
FCF Yield	6.38%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6